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Memory B cells are essential for generating rapid and
robust secondary antibody responses. It has been
thought that the unique cytoplasmic domain of IgG
causes the prompt activation of antigen-experienced
IgG memory B cells. To assess this model, we have
generated a mouse containing IgG1 B cells that
have never encountered antigen. We found that,
upon challenge, antigen-experienced IgG1 memory
B cells rapidly differentiated into plasma cells,
whereas nonexperienced IgG1 B cells did not, sug-
gesting the importance of the stimulation history. In
addition, our results suggest that repression of the
Bach2 transcription factor, which results from anti-
gen experience, contributes to predisposition of
IgG1memoryBcells todifferentiate intoplasmacells.
INTRODUCTION
Humoral memory is characterized by the rapid production of
high titers of high-affinity antigen-specific antibodies, mostly of
the IgG isotypes in the systemic immune system. During their
generation, memory B cells could acquire new traits that make
them intrinsically different from their naive predecessors, which
in turn, at least partly, contribute to the rapid activation of mem-
ory B cells (Good-Jacobson and Shlomchik, 2010). Indeed,
memory B cells have been demonstrated to have a distinct
gene expression profile that differs from naive B cells (Bhatta-
charya et al., 2007; Tomayko et al., 2008). However, which
molecule(s) among these changes is critical to make thememory
B cells better to respond to secondary antigen exposure remains
unclear.
One obvious inherent difference between naive andmemory B
cells is in the structure of the B cell antigen receptor (BCR) (i.e.,
membrane IgM and IgD on naive B cells versus membrane IgG
on memory cells), and this has long been suspected to be the136 Immunity 39, 136–147, July 25, 2013 ª2013 Elsevier Inc.molecular basis for the robust secondary antibody responses
of memory B cells expressing IgG (BCR-intrinsic mechanism)
(Engels et al., 2009; Liu et al., 2010; Martin and Goodnow,
2002). Membrane IgM and IgD both have short, three-amino-
acid heavy-chain cytoplasmic tails that seem incapable of play-
ing any direct role in BCR signaling. By contrast, all membrane
IgG subclasses have unique cytoplasmic domain structures of
28 residues and these are highly conserved among species.
Thus, in addition to BCR signaling executed by the Iga and Igb
heterodimer common to all BCRs, the IgG-type BCRs could
possess additional signaling functions mediated by the cyto-
plasmic domain of IgG (Reth, 1992).
Indeed, in vitro murine studies show that cross-linking of
IgM-type and IgG-type BCRs induced different signaling activity
(Engels et al., 2009; Liu et al., 2010; Wakabayashi et al., 2002).
In vivo studies have also demonstrated the potential of the
unique function of the IgG1 tail. Mice with a targeted disruption
that truncates the cytoplasmic sequence of IgG1 generate
poor antigen-specific IgG1 secondary antibody responses
(Kaisho et al., 1997). However, in thesemice, the B cells express-
ing a truncated IgG1 have lower cell surface BCR expression
than do wild-type IgG1-bearing B cells, raising the possibility
that the reduced IgG1 antibody responses result from decreased
stability of membrane IgG1 expression, rather than from a spe-
cific signaling defect. Another study uses transgenic mice
harboring a chimeric membrane heavy chain consisting of the
extracellular domain of IgM (anti-hen egg lysozyme) and the
cytoplasmic domain of IgG1 (IgM-IgG1 BCR) (Martin and Good-
now, 2002). The B cells expressing an IgM-IgG1 BCR give rise to
ten times more extrafollicular plasma cells than do B cells
expressing an IgM BCR, demonstrating the unique capability
of the IgG1 tail. However, these studies focus on the primary
perifollicular and extrafollicular response. Given that authentic
memory B cells are antigen experienced and many of them are
derived from germinal center (GC) reactions (Good-Jacobson
and Shlomchik, 2010), these experiments do not address the
effect of the IgG1 tail on the activity of post-GC authentic mem-
ory B cells. Therefore the above studies, although suggestive, do
not allow us to draw firm conclusions regarding the issue of
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cient to account for their unique traits.
Indeed, because the initial priming with antigen causes
numerous interconnected changes in the antigen-experienced
IgG1 memory B cells, other BCR-extrinsic changes have been
proposed to be important, mainly based on the in vitro analysis
of human memory B cells. For instance, expression of KLF4,
KLF9, and promyelocytic leukemia zinc finger (PLZF) transcrip-
tion factors, which are important in maintaining cellular quies-
cence, is downregulated in both human IgM- and IgG-typemem-
ory B cells, and enforced expression of these genes in memory
B cells delays their entry into cell cycle (Good and Tangye, 2007).
Here, as a first step to identify a causal factor for the unique
traits of IgG1 memory B cells, we examined the contribution of
BCR-intrinsic and -extrinsic changes in rapid recall responses.
Our data suggest that antigen experience induces repression
of the Bach2 transcription factor, which in turn contributes to
the heightened differentiation activity of IgG1 memory B cells.
RESULTS
Importance of IgG1 Memory B Cells in Secondary
Antibody Responses
To address the mechanisms underlying the rapid and robust
recall responses, we used as a model system the well-char-
acterized antibody (Ab) response to the hapten nitrophenol
(4-hydroxy-3-nitrophenylacetyl [NP]) (Bothwell et al., 1981).
Because recent studies have raised the possibility that IgM-
type memory B cells are able to generate a secondary antigen-
specific IgG1 Ab response (Dogan et al., 2009; Pape et al.,
2011), we first sought to determine the relative contribution of
IgM- and IgG1-type memory B cells to secondary anti-NP IgG1
Ab responses. To specifically deplete IgG1-expressing cells,
we used Cg1-cre 3 iDTR mice, in which the cre recombinase
gene is ‘‘gene targeted’’ to the Cg1 locus so that Cre is
expressed in cells transcribing the g1 constant region, resulting
in expression of the human diphtheria toxin receptor (DTR) and
sensitivity to diphtheria toxin (Buch et al., 2005; Casola et al.,
2006). Mice were immunized with NP-chicken-g-globulin
(CGG) in alum to generate NP-specific memory B cells and
then rested for 60 days, at which time most of the GC B cells
were reduced. The mice were then treated with diphtheria toxin
for 5 days to delete preexisting IgG1-expressing B cells before
secondary NP-CGG immunization. After the toxin treatment,
compared with Cg1-cre control mice, 10% of IgG1+ B cells
were present in the Cg1-cre 3 iDTR mice (Figure 1A, left).
CD38 is a good marker for distinguishing between memory
and GC B cells in mice; the former are CD38+IgG1+ and the latter
are CD38IgG1+ (Ridderstad and Tarlinton, 1998; Takahashi
et al., 2001). Indeed, NP-specific CD38+IgG1+ memory B cells
were efficiently deleted (Figure 1A, right). This significant reduc-
tion resulted in functional consequences, as shown by the fact
that the diphtheria toxin-treated Cg1-cre 3 iDTR mice were
unable to generate a secondary anti-NP high-affinity IgG1 Ab
response (Figure 1C). To confirm that this defect was directly
due to the absence of IgG1 memory B cells, we transferred
wild-type (WT) IgG1 memory B cells into the toxin-treated mice
and were able to recover the secondary response. NP+IgM+
B cells were intact in toxin-treated Cg1-cre 3 iDTR mice (Fig-ure 1B), as was the secondary IgM anti-NP response (Figure S1
available online). Thus, we conclude that IgG1 memory B cells
are the major source of the secondary IgG1 Ab response to NP.
IgG1 Memory B Cells Have an Enhanced Capacity to
Differentiate into Plasma Cells
To define the unique features of IgG1 memory B cells that could
explain the rapid secondary Ab response, we first compared the
properties of IgG1 memory and IgM naive B cells. To do this, we
chose an experimental system with a defined affinity for NP,
because BCR affinity is known to be a critical determinant in B
cell fate decision (Chan et al., 2010), such as in the choice
between extrafollicular plasmablast responses versus GC path-
ways (Paus et al., 2006). Therefore, we made use of Ig VH186.2-
DFL16.1-JH2 gene-targeted mice (B1-8
hi) in which the B cells
express Ig heavy chains that, when combined with an Igl light
chain, produce Abs with a defined affinity for the hapten NP
(Shih et al., 2002). These high-affinity B1-8hi B cells have a
10-fold higher affinity (Ka; 5 3 106 M1) for NP than do germline
B1-8 B cells (Ka; 5 3 105 M1) because of the introduction of a
Trp to Leu mutation at codon 33 of VH186.2 (Allen et al., 1988).
To prepare NP+B1-8hi IgG1memory B cells, B1-8hi IgM B cells
were transferred into naive C57BL/6 mice, which were then
immunizedwith NP-CGG in alum (Figure 2A). The B1-8hi memory
B cells derived from B1-8hi IgM naive B cells, which could be
easily distinguished from recipient B cells on the basis of
CD45.1 or CD45.2 expression, were then purified. As reported
with endogenous NP+ IgG1 memory B cells (Anderson et al.,
2007; Tomayko et al., 2010), these NP+B1-8hi IgG1 memory B
cells expressed higher CD80, CD273, and major histocompati-
bility complex class II molecules (MHC-II) than NP+B1-8hi IgM
naive B cells (Figure 2B).
We then transferred equal numbers of IgM naive or IgG1mem-
ory B cells into CGG in alum-primed C57BL/6 mice. Because
NP+B1-8hi IgG1 memory B cells exhibited the mature follicular
phenotype (CD23hiCD21int), we used the mature follicular frac-
tion of the B1-8hi IgM naive B cells for this assay (Figure 2A).
Recipients were immunized 24 hr later with NP-CGG in PBS,
and spleen cells were examined by multiparameter flow cytom-
etry on day 4 to follow the fates of the NP+B1-8hi IgG1 memory
and NP+B1-8hi IgM naive B cells. There were several notable dif-
ferences. The NP+B1-8hi IgM naive B cells gave rise to more
progeny cells than did the NP+B1-8hi IgG1 memory B cells (Fig-
ure 2C) and, based on Fas and GL7 expression, 60% of the
naive B cells had becomeGC cells, whereas few germinal center
cells were generated by NP+B1-8hi IgG1 memory B cells (Fig-
ure 2D). By contrast, the memory B cells generated a high fre-
quency of plasma cells (55%) (Figure 2E), which is consistent
with previous reports (Benson et al., 2009; Dogan et al., 2009;
Pape et al., 2011).
In order to obtain sufficient NP+ IgG1 memory B cells, we had
to adoptively transfer large numbers of antigen-specific B cells,
and therefore it could be argued that elevating the frequency of
these cells introduced unknown variables that are not represen-
tative of the normal physiologic state. To validate the use of the
adoptive-transfer system, we purified endogenous anti-NP-
specific IgG1 memory B cells from normal C57BL/6 mice. We
analyzed somatic hypermutation and affinity maturation by
single-cell PCR and sequencing VH186.2. About 20% of theImmunity 39, 136–147, July 25, 2013 ª2013 Elsevier Inc. 137
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Figure 1. Secondary High-Affinity IgG1 Responses Are Derived Mainly from IgG1 Memory B Cells
Cg1-cre gene-targeted mice (control) or Cg1-cre 3 iDTR (iDTR; IgG1) mice were immunized with NP-CGG in alum. After 56 days, diphtheria toxin (DT) was
injected intraperitoneally (i.p.) for 3 consecutive days. Two days after the last injection, splenocytes were prepared from each mouse strain.
(A and B) The percentage of NP-specific IgG1 memory B cells (NP+IgG1+CD38+) in the spleen (A) and NP-specific IgM B cells (NP+IgM+) (B) were measured by
flow cytometry. Numbers in each profile indicate the percentage of the gated population. Circles in the right hand plots indicate data from individual mice, and the
bar indicates the mean.
(C) Serum of each mouse was collected at the indicated time points. Soluble NP-CGG was injected i.p. at day 60 after the primary immunization. Sera were
collected at 5 days and 7 days after the rechallenge. Anti-NP high-affinity IgG1 antibodies in sera were measured by ELISA. NP-specific IgG1+CD38+ wild-type
memory B cells were collected from NP-CGG in alum-immunized C57BL/6 mice and transferred to DT-treated iDTR; IgG1 mice at day 59. On the next day,
recipient mice were boosted with soluble NP-CGG and anti-NP IgG1 titer was determined. Each group consists of more than three mice and representative data
of two independent experiments are shown. Data represent the mean ± SD. *p < 0.05.
See also Figure S1.
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Repression of Bach2 in IgG1 Memory B CellsIgG1 memory B cells had germline VH186.2 sequences and
30% of the Trp33 to Leu mutation, suggesting that the affinity
for NP of the majority of IgG1 memory B cells was between 5 3
105 M1 and 5 3 106 M1 (Figure S2A; Furukawa et al., 1999).
These endogenous CD38+NP+IgG1+memory B cells were trans-
ferred into CGG in alum-primed mice and their differentiation
capacity was evaluated. As shown in Figure S2B, endogenous
CD38+NP+IgG1+ memory cells also had a high propensity to
differentiate into plasma cells, like the NP+B1-8hi IgG1 memory
B cells, thus validating the use of the adoptive-transfer approach
for subsequent studies.
Antigen Nonexperienced IgG1 B Cells Have a More
Limited Differentiation Potential
The above observations strongly suggest that the high differen-
tiation capacity of IgG1 memory B cells to become plasma cells138 Immunity 39, 136–147, July 25, 2013 ª2013 Elsevier Inc.is one of the key determinants to explain the rapid kinetics of
secondary Ab responses. To explain the unique properties of
IgG memory B cells, two non-mutually-exclusive mechanisms
have traditionally been postulated. In the BCR-intrinsic model,
the unique IgG cytoplasmic tail is thought to be the primary factor
(Kaisho et al., 1997; Martin and Goodnow, 2002), whereas in the
second model, BCR-extrinsic changes, such as alterations in
transcription factors that take place during priming (Good and
Tangye, 2007), are invoked.
One way to test the first model would be to examine the in vivo
behavior of IgG1-expressing B cells that had never encountered
cognate antigen; however, such cells do not exist in the normal
immune system. As a way around this conundrum, we generated
IgG1-embryonic stem cells (ESCs) by nuclear transfer from
NP+IgG1+ memory B cells derived from C57BL/6 mice, with
the idea that the prerearranged and pre-class-switched Ig heavy
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Figure 2. IgG1 Memory B Cells Have a High
Propensity toDifferentiate into PlasmaCells
(A) Schematic illustration of the transfer
experiment.
(B) Expression of the indicated molecules was
analyzed by flow cytometry. Blue lines indicate the
expression by mature follicular NP+CD38+ IgM
naive B cells collected from B1-8hi gene-targeted
mice. Red lines represent the expression in
NP+CD38+ IgG1 memory B cells generated from
B1-8hi B cells.
(C–E) IgM naive or IgG1 memory B cells were
transferred to CGG in alum-primed B6 recipients.
On the next day, soluble NP-CGG was adminis-
trated i.p. Four days after the rechallenge, spleen
cells were analyzed by flow cytometry.
(C) CD45.1+ donor cell numbers in spleen were
calculated.
(D) The percentage of germinal center B cells
(Fas+GL7+) among donor cells was determined.
Representative flow cytometric data is shown.
Numbers indicate the percentage of cells within
the gate.
(E) Plasma cells derived from donor cells were
analyzed by flow cytometry and their percentage
is plotted on the right.
Flow cytometric data are representative of at least
three experiments. Bar graph represents the
mean ± SD (n = 3–5). **p < 0.01, *p < 0.05. See also
Figure S2.
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Repression of Bach2 in IgG1 Memory B Cellsand l light chain genes in their natural chromosome context
would allow us to characterize such antigen-nonexperienced
IgG1 B cells. Several independent IgG1-ESC lines were estab-
lished and used for making chimeric mice. Among these lines,
we used clone NTB2 throughout the following experiments.
Consistent with a previous study on IgG1 gene-targeted mice
(Waisman et al., 2007), development of the B cells derived
from the IgG1-ESCs was disfavored (Figure S3A), presumablyImmunity 39, 136–because of the competition with blasto-
cyst-derived B cells, which would arise
from precursors in the bone marrow that
undergo sequential Ig gene rearrange-
ment and ultimately express IgM. Never-
theless, NP+IgG1+ B cells were generated
in the bone marrow and present in
the periphery. We examined maturation
stages of these NP+IgG1+ B cells in the
spleen; like peripheral B cells derived
from the previous IgG1 gene-targeted
mice (Waisman et al., 2007), proportions
of the immature (CD23loCD21lo) and
the marginal zone (CD21hiCD23lo) stages
were decreased or increased, respec-
tively, compared with blastocyst-derived
B cells (Figure S3B). Then, to experi-
mentally determine the affinity of the
NP+IgG1+ B cells for NP, we cloned
antibodies from single cells (Figures S3C
and S3D) and determined the affinity for
NP by using thermodynamic character-ization methods, revealing that Ka was 1 3 108 M1 (called
B1-8g1 IgG1 naive B cells hereafter) (Figures S3E and S3F).
Having established the above model, we first compared
expression of CD80, CD273, and MHC-II on mature follicular
NP+B1-8g1 IgG1 B cells with those of NP+B1-8hi IgM naive B
cells; they were found to be identical (Figure 3B). The capacity
of the NP+B1-8g1 IgG1 or NP+B1-8hi IgM naive mature B cells
to mount a recall response was examined by adoptive transfer147, July 25, 2013 ª2013 Elsevier Inc. 139
B
IgM Naive
IgG1 Naive
unstained
C
D
E
A
B6 WT mice
i.p.
CGG in alum NIP-CGG in PBS
IgG1 Naive (NP+IgG1+B1-8g1 B cells)
i.p.
Analysis
IgM Naive (NP+IgM+B1-8hi B cells)
or
i.v.
CD80 CD273 MHC II
M
ax
 (%
)
NIP
C
D
45
.2
+  
ce
lls
 (x
10
3 )
Naive
IgM
Naive
IgG1
B220
C
D
13
8
IgM IgG1
NaiveCells
C
D
13
8+
(%
)
Naive
IgM
Naive
IgG1
IgM IgG1
Naive NaiveCells
Fa
s+
G
L7
+ (
%
)
Naive
IgM
Naive
IgG1GL7
Fa
s
0 102 103 104 105
0
102
103
104
105
38.9
0 102 103 104 105
0
20
40
60
80
100
0 102 103 104 105
0
20
40
60
80
100
0 102 103 104 105
0
20
40
60
80
100
NP-CGG in PBS
or
0 
5 
10 
15 
20 
25 
0 102 103 104 105
0
102
103
104
105
42.1
0 
10 
20 
30 
40 
50 
60 
70 
80 
0 102 103 104 105
0
20
40
60
80
100
0 
10 
20 
30 
40 
50 
60 
70 
0 102 103 104 105
0
102
103
104
105
13.2
0 102 103 104 105
0
102
103
104
105
10.7
Naive
Figure 3. IgG1 Naive B Cells Differentiate in
a Similar Fashion to IgM Naive B Cells
(A) Schematic illustration of the experimental
protocol.
(B) Cell surface expression on mature follicular
NP+CD38+ IgM naive B cells from B1-8hi gene-
targeted mice (blue line) or mature follicular
NP+CD38+ IgG1 naive B cells from chimeric
mice derived from IgG1-ES NTB2 (red line) was
analyzed by flow cytometry. Gray histogram
represents the unstained control.
(C–E) Mature follicular type cells of IgM naive
B cells from B1-8hi gene-targeted mice or IgG1
naive B cells from chimeric mice were sorted
and transferred to CGG in alum-primed CD45.1
C57BL/6 mice. NIP-CGG or NP-CGG in PBS was
injected i.p. on the next day. Four days later, donor
cells were analyzed by flow cytometry. Analysis
was carried out as described in the Figure 2
legend. Bar graph represents the mean ± SD
(n = 3–5).
See also Figure S3.
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Repression of Bach2 in IgG1 Memory B Cellsof the same numbers of these mature follicular type B cells into
CGG in alum-primed B6 mice, followed by immunization with
NP-CGG or NIP-CGG in PBS, respectively (Figure 3A). Because
the affinity for NP of B1-8g1 IgG1 B cells was 20-fold higher
than that of B1-8hi IgM B cells, to minimize the effects of affinity
difference on biological activity, we used NIP-CGG, instead of
NP-CGG, for stimulation of B1-8hi IgM B cells in these experi-140 Immunity 39, 136–147, July 25, 2013 ª2013 Elsevier Inc.mental settings; 4-hydroxy-5-indo-3-ni-
trophenyl acetyl (NIP) was reported to
bind to the Ig composed of VH186.2-
DFL16.1-JH2 and l1, 10-fold higher
than NP (Imanishi and Ma¨kela¨, 1973). As
shown in Figures 3C–3E, NP+B1-8g1
IgG1 B cells expanded to a similar extent,
compared with NP+B1-8hi IgM B cells,
and both of these B cell types underwent
predominantly GC reactions rather than
differentiation into plasma cells.
These observations suggest that ex-
pression of the membrane type IgG1
heavy chain, per se, is not sufficient to
explain the heightened capacity of anti-
gen-experienced IgG1 memory B cells to
differentiate into plasma cells and that
additional changes take place during
in vivo priming, thereby contributing
to such traits. This hypothesis predicts
that NP+B1-8g1 naive IgG1 B cells, after
being antigen experienced, should also
acquire the heightened differentiation
capability at the memory stage. To test
this prediction, NP+B1-8g1 naive IgG1
B cells were labeled with carboxyfluor-
escein succinimidyl ester (CFSE), trans-
ferred, and immunized (upper line in
Figure 4A). Then, we purified the resultant
NP+CD38+ IgG1 B cells, almost all ofwhich had lost CFSE, fitting the definition ofmemory cells, having
responded to antigenic stimulation and retained CD38 expres-
sion (Figure 4B; Tarlinton, 2006).We compared their in vivo differ-
entiation capability with parental mature follicular NP+B1-8g1
naive IgG1B cells (lower line in Figure 4A). As shown in Figure 4C,
the antigen-experiencedmemory IgG1 B cells manifested higher
differentiation activity, comparedwithparental naive IgG1Bcells.
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Figure 4. Antigen Experience Affects
Differentiation Activity of IgG1 B Cells
(A) Schematic illustration for the generation of
antigen-experienced NP+IgG1+ memory B cells
and the transfer experiment.
(B) B cells collected from mature follicular naive
IgG1 B1-8g1 B cells were labeled with CFSE and
transferred to CD45.1 C57BL/6 mice. The mice
were immunized with NP-CGG in alum i.p. or not.
The donor cells were analyzed for the expression
of CFSE, CD38, and IgG1 by flow cytometry
20 days later. Gray histogram represents CFSE-
unlabeled recipient B cells. Data are representa-
tive of two independent experiments.
(C) An antigen-experienced NP+IgG1+ memory or
parental NP+IgG1+ naive B cells were purified
and transferred to CGG in alum-primed CD45.1
C57BL/6 mice, and differentiation ability was as-
sessed by flow cytometry 4 days later after soluble
NP-CGG rechallenge as described in the Figure 2
legend.
(D) The amount of each mRNA in NP+IgG1+
naive B cells and antigen-experienced NP+IgG1+
memory B cells was measured by qRT-PCR.
Data are representative of at least two indepen-
dent experiments. Bar graph represents the
mean ± SD (n = 3–5). **p < 0.01, *p < 0.05.
Immunity
Repression of Bach2 in IgG1 Memory B CellsPax5 and Bach2 Are Reduced in IgG1 Memory B Cells
The above results suggested the importance of BCR-extrinsic
changes. To gain insights into what these might be, we first
compared the amount of key transcription factors for plasma
cell differentiation between NP+B1-8hi memory IgG1 and
mature follicular NP+B1-8hi naive IgM B cells. Blimp-1, IRF-4,
and XBP-1 are required for plasma cell differentiation (Iwakoshi
et al., 2003; Klein et al., 2006; Martins and Calame, 2008),
whereas factors such as Bcl-6, Pax5, and Bach2, which are
found in GC or activated B cells, but not in plasma cells, are
known to suppress these processes (Basso and Dalla-Favera,
2012; Cobaleda et al., 2007; Igarashi et al., 2007). The plasma
cell differentiation factors (Blimp-1, IRF-4, XBP-1) were ex-
pressed at similar amounts in the two cell types (Fig-
ure 5A), whereas the amounts of Pax5, Bach2, and Bcl-6,
were significantly reduced in NP+B1-8hi memory IgG1 B cells
(Figure 5B). Given that Bcl6 ablated mice can generate normalImmunity 39, 136–secondary anti-NP IgG1 responses
(Toyama et al., 2002), involvement of
Bcl6 in the enhanced plasma cell differ-
entiation capability would seem unlikely,
and therefore we focused on Pax5 and
Bach2. Reflecting the amount of RNA,
expression of Pax5 and Bach2 proteins
was also decreased in NP+B1-8hi mem-
ory IgG1 B cells compared to NP+B1-8hi
IgM naive B cells (Figure 5C). In contrast
to Bach2, reduction of Pax5 protein was
modest.
As shown in Figure 4D, the antigen-
experienced memory IgG1 B cells
derived from B1-8g1 B cells showedreduced expression of Pax5, Bach2, and Bcl6 compared with
parental NP+B1-8g1 naive IgG1 B cells.
Reduction of Bach2 in IgG1 Memory B Cells Promotes
Plasma Cell Differentiation
To test whether reduction of Pax5 and Bach2 induces IgG1
memory B cells to preferentially differentiate into plasma cells,
we examined the effects of reduction of these factors in another
context, in IgM naive B cells, on their differentiation to plasma
cells. Prestimulated B1-8hi naive IgM B cells were transduced
with gene-silencing retroviral constructs (Figure 6A) and trans-
ferred into C57BL/6 mice, which were then immunized with
NP-CGG in alum. As demonstrated in Figure 6B, there was a
higher proportion of plasma cells from Bach2 silenced B cells
compared with mock-transduced B cells, whereas there was
no significant enhancement from Pax5 silenced B cells. To
further test the importance of Bach2 in IgG1 memory B cells,147, July 25, 2013 ª2013 Elsevier Inc. 141
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Figure 5. Expression of Bach2 Is Reduced in
IgG1 Memory B Cells
(A and B) Mature follicular naive NP+IgM+ B cells
were sorted from B1-8hi mice. NP+CD38+B1-8hi
IgG1 memory B cells were isolated as shown in
Figure 2A. The amount of each mRNA in these
cells was measured by qRT-PCR. The data were
normalized to the amount of Gapdh. As a control,
CD138+ plasma cells were sorted from spleno-
cytes of NP-CGG in alum-immunized C57BL/6
mice. Bar graph represents the mean ± SD. The
data are representative of at least three indepen-
dent experiments.
(C) The amount of Pax5 or Bach2 protein was
measured by intracellular flow cytometric analysis.
Mature follicular naive NP+IgM+ B cells were pre-
pared from B1-8hi mice. NP+CD38+B1-8hi IgG1
memory B cells were prepared as Figure 2A. Then,
these B cells were fixed and permeabilized with
paraformaldehyde followed by staining with Pax5
antibody or Bach2 antibody. CD3+ T cells were
used as a negative control for Pax5. Spleen B cells
from Bach2-deficient mice (Bach2f/f 3 Cd79a-
creKI/wt) were used as a negative control for Bach2.
The numbers in each profile indicate geometric
mean fluorescence intensity (gMFI) of each pop-
ulation. The data are representative of at least
three independent experiments.
**p < 0.01. See also Figures S4 and S5.
Immunity
Repression of Bach2 in IgG1 Memory B Cellswe examined the effects of haploinsufficiency of Bach2
on plasma cell differentiation by using NP+B1-8hi memory IgG1
B cells from Bach2flox/+ 3 ERT2-cre mice. As shown in Figures
6C and 6D, the haploinsufficient memory B cells manifested
increased differentiation activity. Thus, our data, together with
the previous evidence that Bach2 binds to the Blimp1 promoter
region and represses its transcription (Ochiai et al., 2006),
demonstrate that the reduction of Bach2 is probably a direct
cause for conferring high plasma cell differentiation propensity
on IgG1 memory B cells.
mTOR Is a Potential Regulator for Bach2 Repression
To address the potential mechanisms by which antigen-experi-
enced B cells induce repression of Bach2, we focused here
upon the early regulatory events initiated by BCR stimulation.
To do this, we employed the in vitro experimental system.
In vitro stimulated B cells (anti-BCR+IL-4+anti-CD40) underwent
repression of Bach2. Among various inhibitors that are well
known to modulate the transcription processes in B cells, rapa-
mycin and API-2 (an AKT inhibitor) significantly inhibited the
Bach2 repression (Figures 7A and S6A). Because S6 kinase,
one of the readouts of mammalian target of rapamycin (mTOR)
activation, was activated in in vitro stimulated B cells (Figure 7A),
our results demonstrate that antigen-stimulated B cells acti-
vate a phsophatidyl inositol 30-OH kinase (PI3K)-AKT-mTOR
pathway, which in turn is important for initiation of Bach2 repres-
sion. In vivo data support this conclusion: both antigen-induced
phosphorylation of S6 protein and Bach2 repression were
inhibited by rapamycin treatment (Figure 7B).
Because the transcription factor Foxo1 is known to function
in the AKT pathway (Rao et al., 2012), we also examined the142 Immunity 39, 136–147, July 25, 2013 ª2013 Elsevier Inc.involvement of Foxo1 by in vitro experiments. Stimulation-medi-
ated Bach2 repression was further enhanced by treatment of a
Foxo1 inhibitor (Figures 7C and S6B; Nagashima et al., 2010).
Conversely, when B cells were retrovirally transduced with a
constitutively active form of Foxo1 (Foxo1-CA) (Tang et al.,
1999), this Bach2 repression was reduced (Figures 7D and
S6C). These results suggest that Foxo1 could be a potential
modulator for Bach2 repression in the PI3K-AKT-mTOR
pathway.
DISCUSSION
In this study, we began to address a long-standing question
regarding the mechanisms that govern heightened secondary
IgG1 antibody responses. We were able to analyze antigen-non-
experienced IgG1 B cells by establishing IgG1-ESCs via nuclear
transfer from NP+IgG1+ memory B cells. Our data show that the
IgG1 cytoplasmic region, per se, is not sufficient to explain the
unique properties of antigen-experienced IgG1 memory B cells
and that changes in the amounts of transcription factors occur
during priming, thereby contributing to the heightened differenti-
ation activity of the resultant memory B cells. These conclusions
are supported by the following three lines of evidence. First, in
contrast to antigen-nonexperienced IgG1 B cells, IgG1 memory
B cells had a high propensity to differentiate into plasma cells.
Second, expression of the Pax5 and Bach2 transcription factors
was downregulated in the IgG1 memory B cells. Third, by further
reducing the expression of Bach2 in IgG1 memory B cells, their
differentiation into plasma cells was enhanced.
Based on in vitro analysis of human memory B cells, it is often
assumed that IgG-type memory B cells proliferate more rapidly
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Figure 6. Reduced Expression of Bach2
Facilitates Plasma Cell Differentiation
(A) Prestimulated (see Experimental Procedures)
B1-8hi IgM B cells were transduced with retrovi-
ruses carrying gene silencing constructs for
Bach2, Pax5, or empty vector, and further cultured
for another 2 days. The transduced GFP+ cells
were sorted and gene silencing efficiency was
evaluated by qRT-PCR. Bar graph represents the
mean ± SD (n = 3).
(B) B1-8hi IgM B cells transduced with the
indicated retroviruses were transferred to naive
C57BL/6 mice followed by immunization with
NP-CGG in alum. After 4 days, the donor cells
in the spleen gated on GFP+ cells were analyzed
for the expression of CD138 and B220 by flow
cytometry. The bar in the graph indicates the
mean ratio.
(C and D) Antigen-experienced NP+CD38+IgG1+
memory B cells from Bach2+/+ 3 ERT2-creKI/wt 3
B1-8hi or Bach2f/+ 3 ERT2-creKI/wt 3 B1-8hi mice
were generated as illustrated in Figure 2A. Mice
were treated with 2 mg tamoxifen by p.o. for 3
consecutive days. At 2 days after last administra-
tion, the cells were collected from spleen cells and
used for the experiments.
(C) NP+CD38+ IgG1memory B cells from Bach2+/+
3 ERT2-creKI/wt 3 B1-8hi or Bach2f/+ 3 ERT2-
creKI/wt 3 B1-8hi mice were analyzed for
measuring the expression of Bach2 by intracellular
flow cytometric analysis as described in Figure 5C
legend.
(D) The above IgG1 memory B cells were trans-
ferred to CGG in alum-primed C57BL/6 recipients.
On the next day, soluble NP-CGG was adminis-
trated i.p. At 4 days after the rechallenge, spleen
cells were analyzed by flow cytometry as
described in Figure 2 legend.
The data represent three independent experi-
ments. Bar graph represents the mean ± SD (n =
3–5). **p < 0.01, *p < 0.05.
Immunity
Repression of Bach2 in IgG1 Memory B Cellsthan do naive IgM B cells, thereby at least partly accounting for
the heightened secondary antibody response (Tangye et al.,
2003). However, the in vivo expansion capacity of mouse IgG1
memory B cells shown here appears instead to be somewhat
less than that of the naive IgMB cells. This disparity might simply
reflect species differences between human and mouse. Alterna-
tively, it could be caused by the fact that the human in vitro cul-
ture system with CD40L, IL-2, and IL-10 (Arpin et al., 1997) does
not adequately recapitulate the in vivo GC processes, thus lack-
ing the detection of high rate of cell division of IgM centroblasts
that normally occurs in vivo. Because Pax5 and Bach2, key
transcription factors for generating GC B cells, are similarly ex-
pressed at high amounts in both human and mouse IgM naive
B cells (Robichaud et al., 2004; Sasaki et al., 2000), it is reason-
able to anticipate that upon encounter with appropriate T cell-
dependent antigens, human IgM naive B cells would enter the
GC pool where they would undergo extensive proliferation in
this in vivo context. Thus, this GC-dependent proliferation of
human IgM naive B cells would be missed in the in vitro assay
system. By contrast, assuming that human IgG1memory B cells,like their mouse counterparts, prefer to differentiate into plasma
cells rather than entering the GC pool, this GC-dependent effect
would be minimized.
Another difference between our results and those from a
previous study is the biological activity of the antigen-nonexper-
ienced IgG1-type B cells, which we have demonstrated to have
similar in vivo activity to IgM-type naive B cells. By contrast,
the previous study comparing antigen-nonexperienced B cells
expressing a transgenic anti-HEL chimeric IgM-IgG1 BCR or a
transgenic IgM BCR shows that although the initial proliferation
of IgM-IgG1 B cells is similar to that of the IgM B cells, the cyto-
plasmic IgG1 tail markedly enhances survival at the plasmablast
stage (Martin and Goodnow, 2002). One explanation could be
that the affinity difference for antigens in the two experimental
systems (the affinity of the VH186.2 germline-type BCR for NP
is about Ka = 5 3 105 M1, whereas the transgenic BCR
for hen egg lysozyme [HEL] is Ka = 2 3 1010 M1) might
cause such differential outcomes (Padlan et al., 1989). It is
well known that high-affinity antigen generates a robust extra-
follicular plasmablast response, whereas low-affinity antigenImmunity 39, 136–147, July 25, 2013 ª2013 Elsevier Inc. 143
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Figure 7. Bach2 Repression Was Suppressed by Rapamycin
(A and C) Purified C57BL/6 spleen B cells were treated with each inhibitor (shown on x axis) for 60 min: mTOR, Rapamycin (20 nM); ERK, PD98059 (50 mM); JNK,
SP600125 (10 mM); p38, SB203580 (10 mM); NF-kB, IKK inhibitor (10 mM); AKT, API-2 (20 mM); or Foxo1, AS1842856 (1 mM). These cells were further cultured with
CD40 antibody (2 mg/ml), IL-4 (10 ng/ml), and IgM antibody (1 mg/ml) for 6 or 24 hr in the presence of each inhibitor. The amount of Bach2mRNA in these cells was
measured by qRT-PCR. The data were normalized to the amount ofGapdh. The phosphorylation status of S6K, AKT (Ser473), and Foxo1 (Ser256) in the absence
of inhibitors was analyzed by immunoblotting.
(B) Naive B cells from CD45.1 B1-8hi gene-targeted mice were transferred to C57BL/6 mice followed by immunization with NP-CGG in alum. Rapamycin
(300 mg/kg) or PBS (control) were injected i.p. on day1 and day 0. At 24 hr after Ag injection, phosphorylation status of S6 protein of immunized donor B cells and
parental naive B cells was measured by intracellular flow cytometric analysis. The donor B cells of immunized mice or naive B cells from B1-8hi gene-targeted
mice were collected by sorting and the amount of Bach2 mRNA was measured by qRT-PCR.
(D) Purified C57BL/6 spleen B cells were prestimulated with CD40 antibody (2 mg/ml), IL-4 (10 ng/ml), and IgM antibody (1 mg/ml) for 1 day and infected with a
mock or Foxo1-CA retrovirus. The infected cells were further cultured for 48 hr and infected GFP+ and noninfected GFP cells were sorted. The amounts of Bach2
mRNAwere measured by qRT-PCR. Bar graph represents the mean ± SD. The data were the representative of at least three independent experiments. *p < 0.05.
See also Figure S6.
Immunity
Repression of Bach2 in IgG1 Memory B Cellsdirects the B cells into the GC reaction (Paus et al., 2006). In this
regard, our antigen-nonexperienced IgG1 B cells prefer to enter
the GC pathway. Thus, it is possible that the cytoplasmic IgG1
tail might play a critical role at the extrafollicular plasmablast,
but not the GC, stage. Another explanation is that the use of144 Immunity 39, 136–147, July 25, 2013 ª2013 Elsevier Inc.an adjuvant can affect the outcome. In the HEL system, com-
plete Freund’s adjuvant was used for immunization (Martin
and Goodnow, 2002), whereas in our experiments a soluble
antigen was injected into carrier protein-primed mice. Thus,
for instance, in contrast to the HEL case, contributory effects
Immunity
Repression of Bach2 in IgG1 Memory B Cellsof dendritic cells (DCs) and inflammatory cells to T cells and B
cells could be minimized in our assay system. If so, we consider
this an advantage, because it provides a simpler system with
fewer variables to compare the responses of naive versus
memory B cells.
Pax5 controls the gene expression program of B cells,
whereas Blimp1 orchestrates the transcription program of termi-
nally differentiated plasma cells (Shapiro-Shelef and Calame,
2004). Despite such an inverse correlation, the reduction of
Pax5 observed in IgG1 memory B cells appears not to directly
influence the heightened differentiation capability of IgG1 mem-
ory B cells. Instead, our data suggest that reduction of Bach2
plays a more direct role. Three lines of previously reported evi-
dence also support this idea. First, it is reported that the loss
of Pax5 alone in mouse mature B cells is not sufficient for induc-
tion of terminal plasma cell differentiation (Horcher et al., 2001).
Second, on the other hand, absence of Bach2 induces a striking
increase in the onset and rate of plasma cell differentiation upon
in vitro lipopolysaccharide (LPS) stimulation, and this Bach2
response is strongly dose dependent (Muto et al., 2010). Finally,
Bach2, but not Pax5, binds directly to the Blimp1 gene, PRDM1,
thereby repressing it (Ochiai et al., 2006; Shapiro-Shelef and
Calame, 2004).
In regard to the Bach2 repression mechanism, our in vitro data
suggest that initiation of this repression is induced by mTOR
pathway. In vivo rapamycin treatment also supports this idea,
although we cannot completely exclude the possibility that the
observed in vivo effects might not be B cell intrinsic, but rather
might be mediated by some other cells of the immune system.
In the case of CD8+ T cells, sustained PI3K-AKT-mTOR activity
is known to inhibit Foxo1, which acts as a molecular switch to
simultaneously induce T-bet expression, thereby promoting
the terminal differentiation of effector T cells (Rao et al., 2012).
Thus, it is reasonable to speculate that B cells might utilize the
similar mechanism; antigen-experienced B cells repress Bach2
expression by the sustained PI3K-AKT-mTOR activity, which
brings these B cells into the predisposed state for Blimp-1 induc-
tion and subsequent plasma cell differentiation.
Recent reports demonstrate that, in contrast to IgG memory
B cells, IgM memory B cells rather prefer to induce secondary
GC reactions (Dogan et al., 2009; Pape et al., 2011), therefore
prompting us to examine the status of Bach2 in IgM memory
B cells. Correlating with such functional data, reduction of
Bach2mRNA and protein in NP+ IgMmemory B cells was limited
compared with that observed in NP+ IgG1 memory B cells
(Figure S5). In regard to mechanisms causing differences in the
levels of Bach2 between IgG1 and IgM memory B cells, the
following three possibilities can be envisaged. First, given that
IgM memory B cells are generated earlier than IgG1 memory
B cells (Taylor et al., 2012), spending relatively a shorter time
for the expansion phase (in the case of IgM memory cells) might
limit the downregulation of Bach2. Second, the IgG1 tail might
facilitate Bach2 downregulation during generation of IgG1mem-
ory B cells. Finally, rather than induction for Bach2 repression, its
maintenance mechanism could differ between IgM and IgG1
memory B cells; the established repressed state for Bach2might
be well maintained in IgG1 but not IgM memory B cells. Addi-
tional studies are underway to define which of the preceding
possibilities is most likely.Although our experiments do not rule out a role for the IgG1
cytoplasmic domain in the unique traits of IgG1 memory B cells,
they demonstrate that this domain alone is insufficient to confer
the heightened differentiation activity of IgG1 memory B cells. In
addition, our data strongly support the concept that antigen
experience induces repression of Bach2 (one of the BCR-
extrinsic changes) in IgG1 memory B cells, which in turn contrib-
utes to rapid humoral recall responses.
EXPERIMENTAL PROCEDURES
Mice
B1-8hi gene-targeted mice, Cg1-cre gene-targeted mice, iDTR mice,
and Cd79a-cre mice were provided by M. Nussenzweig (Shih et al., 2002),
K. Rajewsky and S. Casola (Casola et al., 2006), A. Waisman (Buch et al.,
2005), and M. Reth and E. Hobeika (Hobeika et al., 2006), respectively.
Rosa26-ERT2-cre gene-targeted mice were purchased from Taconic Firm.
B1-8 germline gene-targeted (B1-8ge) mice and flox-Bach2 mice were
generated with Bruce4 ESCs. To generate IgG1-ESC mice, the nuclei of
NP+Igl+CD38+ IgG1 memory B cells derived from C57BL/6 mice were trans-
ferred to nucleus-expelled BDF1 unfertilized eggs. Chimeric mice were gener-
ated by the ESC injection into blastocysts of BALB/c mice. All the mice were
maintained under specific-pathogen-free conditions. The protocols for animal
experiments were approved by the RIKEN Animal Research Committee.
Immunization
For primary responses, mice were injected intraperitoneally (i.p.) with 100 mg
of NP-CGG precipitated with Imject alum (Thermo Fisher Scientific). For recall
responses, 50 mg of soluble NP-CGG in PBS was injected i.p.
In Vivo Cell Depletion
Mice were injected i.p. with 100 ng of diphtheria toxin (4 ng DT/g body weight;
Sigma) for 3 consecutive days.
Adoptive Transfers
For generating memory B cells, purified CD45.1+B1-8hi B cells containing 13
105 NP-binding B cells were transferred intravenously (i.v.) into C57BL/6 mice.
On the next day, 100 mg of NP-CGG precipitated with Imject alumwas injected
i.p. Thirty days later, spleen cells were collected and NP-specific IgG1memory
B cells were sorted after the depletion of dump gate-positive cells viamagnetic
beads column system. NP-binding naive B cells were sorted from B1-8 gene-
targeted mice. Sorted 5,000 NP-binding cells were transferred to recipient
mice i.v. and the mice were boosted with 50 mg of soluble NP-CGG in PBS
i.p. on the next day.
Flow Cytometric Analysis
Single-cell suspensions lysed of red blood cells were stained with fluoro-
chrome-conjugated antibodies. For intracellular staining, the cells were fixed
and permeabilized with a Foxp3 staining kit (eBioscience) followed by staining
with anti-Pax5 (Santa Cruz Biotechnology), Bach2 antibody (established in our
laboratory), or phosho-S6 ribosomal protein (Cell Signaling Technology). The
stained cells were analyzed by FACSCantoII (BD Bioscience).
In Vitro Culture
Purified naive B cells from spleens of C57BL/6 mice were pretreated with
various inhibitors for 60 min. The cells were further cultured with CD40 anti-
body (2 mg/ml; BioLegend), IL-4 (10 ng/ml; R&D), and IgM antibody (1 mg/ml;
Jackson ImmunoResearch) at 37Cunder 5%CO2 for 6 or 24 hr in the absence
or presence of each inhibitor. For retrovirally gene transfer experiments, pres-
timulated B cells were infected with retrovirus and further cultured for 48 hr.
The GFP+ or GFP cells were sorted for the assay via FACSAria.
Enzyme-Linked Immunosorbent Assay
NP20-BSA or NP1-BSA (for high affinity) was used as the capture antigen. After
incubation with serially diluted sera, detections were done with horseradish
peroxidase-conjugated anti-mouse IgM or IgG1 antibodies (SouthernBiotech)Immunity 39, 136–147, July 25, 2013 ª2013 Elsevier Inc. 145
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Repression of Bach2 in IgG1 Memory B Cellsand SureBlue (KPL) substrate. The absorbance at 450 nm was measured with
a microplate reader (Bio-Rad).
Quantitative RT-PCR
Total RNA was extracted with TRIzol (Invitrogen) and DNaseI (Invitrogen)-
treated RNA was reverse transcribed with Super Script III (Invitrogen).
Quantitative PCR was performed with SYBR Green (Invitrogen) and the
ABI StepOnePlus realtime PCR system (Applied Biosystems).
RNAi Gene Silencing Assay
For generating the gene silencing vector, the target sequence was inserted to
the pMYs retroviral vector via the BLOCK-iT polII miR RNAi system (Invitro-
gen). Prestimulated B cells purified from B1-8hi gene-targeted mice were
infected and GFP+ cells were analyzed by flow cytometry.
Measurement of BCR Affinity
To examine NP-binding abilities of BCRs, their Fab regions were bacterially
expressed. The affinity was measured by isothermal titration calorimetry
(ITC) method with Fab proteins and NP-Cap (Biosearch Technologies).
Statistical Analysis
Statistical analyses were performed by a two-tailed unpaired Student’s t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.immuni.2013.06.011.
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